Newsletter: UP Chemists Synthesize New Hybrid Molecules That Limit Cancer Cell Spread

[THIS IS A PRESS RELEASE]

By: Eunice Jean C. Patron

Graphical abstract of the study. (Photo credit: Concio et. al., 2025)

According to the International Agency for Research on Cancer (IARC), the Philippines recorded nearly 189,000 new cancer cases and more than 113,000 cancer-related deaths in 2022. Globally, IARC also projects that the number of new cases will rise to over 35 million by 2050, which is a 77% increase from 2022 figures. Meanwhile, the 2025 Philippine National Cancer Summit reports that more than 180,000 new cases are diagnosed each year and cancer is estimated to cause over 300 Filipino deaths daily. These alarming statistics highlight the urgent need for continued research and innovation in cancer treatment.

Newsletter: UP Study Identifies Potential Biomarkers for Early Lung Cancer Detection

[THIS IS A PRESS RELEASE]

By: Eunice Jean C. Patron

Graphical abstract of the study. (Photo credit: Dimayacyac-Esleta et al., 2025)

According to the International Agency for Research on Cancer, lung cancer is the leading cause of cancer-related deaths worldwide, with nearly 2 million deaths. In the Philippines in 2022, it recorded 23,728 new cases—making it the second most common cancer after breast cancer—and caused 20,953 deaths, the highest among all cancer types. Non-small cell lung carcinoma (NSCLC) is the most common type of lung cancer, accounting for more than 80% of cases. Experts say that late diagnosis and challenges in treating late-stage cases are the main factors affecting the cancer mortality rate, including NSCLC.